申请人:American Hoechst Corporation
公开号:US04186199A1
公开(公告)日:1980-01-29
What is disclosed are ##STR1## wherein X is hydrogen, halogen or trifluoromethyl; Y is hydrogen, halogen or trifluoromethyl; R is hydrogen, loweralkyl, cycloalkyl, phenyl, halophenyl, furyl, pyridinyl, 4-methylpiperazin-1-ylethyl or phenylloweralkyl; R.sup.1 is hydrogen; n and m are independently 0 or 1, but n is not 0 when m is 1, and the bonds between ring positions 1 and 2 and between positions 6 and 7 are respectively saturated when n and m are 1 and are unsaturated when n and m are 0; pharmaceutically acceptable acid addition salts thereof; methods of preparing said compounds; pharmaceutical compositions including said compounds; methods of treatment using the compounds; and intermediates therefor. These compounds are useful as analgesic and anti-inflammatory agents, as well as intermediates for the preparation of other pharmaceutically active compounds.
所披露的是##STR1##,其中X为氢、卤素或三氟甲基;Y为氢、卤素或三氟甲基;R为氢、较低烷基、环烷基、苯基、卤苯基、呋喃基、吡啶基、4-甲基哌嗪-1-乙基或苯基较低烷基;R.sup.1为氢;n和m独立地为0或1,但当m为1时,n不为0,并且当n和m为1时,环位置1和2之间的键和位置6和7之间的键分别饱和,当n和m为0时,键是不饱和的;其药学上可接受的酸盐;制备所述化合物的方法;包括所述化合物的药物组合物;使用这些化合物的治疗方法;以及其中间体。这些化合物可用作镇痛和抗炎药物,以及其他药用活性化合物的制备中间体。